Placeholder

View on Med Ed: Refining the Formula

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 2091. Category: .

Product Description

Amid public protests from high-profile figures such as former AHA President Clyde Yancy, M.D., and National Institutes of Health Director Francis Collins, M.D., Ph.D., in June the Accreditation Council for Continuing Medical Education (ACCME) provided additional guidance to its 2004 Standards for Commercial Support related to the role of ACCME-defined commercial interest employees in ACCME-accredited CME.
The guidance marks the second time in two years that ACCME has issued clarifications in response to questions from providers regarding under which circumstances employees of ACCME-defined commercial interests can plan, speak, and present in accredited CME.
In a written statement released with the additional guidelines, ACCME emphasized its objective to support the free flow of scientific exchange while safeguarding accredited CME from commercial influence, but recognized the importance of including reporting about the discovery phase of product development, as well as the involvement of employees of ACCME-defined commercial…

Sidebar:
ACCME Gives More Guidance for Industry CME Involvement
Showcase

Thought Leaders
ROBERT JACKLER, M.D.
Associate Dean, Postgraduate Education, Stanford University School of Medicine, a research-intensive medical school that improves health through leadership and collaborative discoveries and innovation in patient care, education, and research. For more information, visit med.stanford.edu.
NORMAN KAHN JR., M.D. Executive VP and CEO, the Council of Medical Specialty Societies (CMSS), a nonprofit group that provides a forum for collaboration to influence policy, medical education, and accreditation from a broad, cross-specialty perspective. For more information, visit cmss.org.
FREDA LEWIS-HALL, M.D. Senior VP and Chief Medical Officer, Pfizer Inc., a global, research-based pharmaceutical company. For more information, visit pfizer.com.
KEVIN PHO, M.D. Physician with an internal medicine primary care practice based in Nashua, N.H., and author of a blog, KevinMD.com, that offers provocative physician commentary on breaking medical news. For more information, visit kevinmd.com.
PETER PITTS. President and Co-Founder, the Center for Medicine in the Public Interest, a nonprofit, nonpartisan
organization promoting solutions that advance medical progress, reduce health disparities, extend life, and make healthcare more ­affordable, preventive, and patient-centered. For more information, visit cmpi.org.
PHILIP PIZZO, M.D. Dean, Stanford University School of Medicine, a research-intensive medical school that improves health through leadership and collaborative discoveries and innovation in patient care, education, and research. For more information, visit med.stanford.edu.
JAMES SCULLY JR., M.D. President, the Council of Medical Specialty Societies (CMSS), a nonprofit group that provides a forum for collaboration to influence policy, medical education, and accreditation from a broad, cross-specialty perspective. For more information, visit cmss.org.

FEEDBACK